TNF and cancer: Therefore, a more detailed understanding of the additional signaling events that control this switch should provide novel approaches for therapeutic intervention in RIP1 or TNF-driven pathologies such as chronic inflammatory diseases, ischemia-reperfusion injuries and cancer.